Last reviewed · How we verify

NCT06699264: BFR

Effects of Low-intensity Strength Training With Concomitant Blood Flow Restriction on Pain Perception in Patients With Anterior Cruciate Ligament Surgery

Completed NA Last updated 17 April 2025
What this trial tests

NA trial testing Blood Flow Restriction Training in Anterior Cruciate Ligament Injury in 30 participants. Completed in 21 December 2024.

Timeline
1 March 2023
Primary endpoint
21 December 2024
21 December 2024

Quick facts

Lead sponsorPraxisklinik Rennbahn AG
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment30
Start date1 March 2023
Primary completion21 December 2024
Estimated completion21 December 2024
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Praxisklinik Rennbahn AG

Who can join

Adults 18 to 60, any sex, with Anterior Cruciate Ligament Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

After surgical treatment of a tear of the anterior cruciate ligament, physiotherapeutic exercises are done as standard therapy. This is to achieve a rapid improvement in pain and knee function. In this study, the Investigators examine how low-intensity strength training with simultaneous restriction of blood flow works and whether it is effective and well tolerated. For this purpose, a pressure cuff is applied to the leg during training. Participation in this study will last four weeks for each participant. The Investigators will invite participants for 11 study visits. One appointment will last about 30 minutes. If a participant decides to take part in the study, they will be randomly assigned to one of two groups. The participants will belong to either an experimental group or the control group. In the experimental group, the participants will be treated with the intervention method. The intervention method involves 4 weeks of low-intensity strength training with an additional pressure cuff on the leg, which should lead to improved adaptations to the muscle as well as a reduction in pain. In the control group, the participants will receive the same strength training only without the additional pressure cuff. The benefit is that in addition to the participants actual rehabilitation program, each participant will receive free training to build their muscles. This could contribute to an accelerated rehabilitation process and a faster build-up of strength as well as an improvement in pain. It is additionally possible that the participants will help future patients with their participation. The intervention method for strength training with simultaneous restriction of blood flow (Blood Flow Restriction Training) has been studied for some time. There is good evidence of improved muscle, tendon and pain adaptations in both healthy individuals and patients with ACL injury. Whether this training method also has an effect on pain perception will be investigated in this study. Participants may experience side effects if they are treated with the intervention method (low-intensity strength training with simultaneous restriction of blood flow). The Investigators may not yet know all the risks and side effects of the intervention method. So far, the following risks and side effects are known: * Temporay numbness * Muscle soreness * Pressure sensation

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of blood flow restriction training in early postoperative rehabilitation after ACL reconstruction: a randomised controlled trial.
    Barzyk P, Fiedler C, Schlag M, Heitner A, et al · · 2025 · PMID 41613017 · DOI 10.3389/fspor.2025.1689257

Verify or expand the search:

Other trials of Blood Flow Restriction Training

Trials testing the same drug.

Other recruiting trials for Anterior Cruciate Ligament Injury

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06699264.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing